MedTrace Logo

Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy

NCT03613792 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2023-07-27

No results posted yet for this study

Summary

This randomized controlled pilot clinical trial will enroll patients undergoing dynamic flexible bronchoscopy will be randomized to receive one of the two anesthetic combinations described above. The study will determine if there is a difference when considering patient and physician and satisfaction when performing DFB. Also, safety and efficacy of the two pharmacological combinations (fentanyl + midazolam and remifentanil + ketamine) used will be evaluated.

Conditions

  • Bronchoscopy

Interventions

DRUG

Remifentanil

Opioid analgesic

DRUG

Fentanyl

Opioid analgesic

DRUG

Midazolam

Benzodiazepine

DRUG

Ketamine

Analgesic

Sponsors & Collaborators

Principal Investigators

  • Satya Krishna Ramachandran, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-30
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03613792 on ClinicalTrials.gov